Joaquin Duato is Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, a position he assumed in January 2011. A member of the Johnson & Johnson Management Committee, he is responsible for the global pharmaceutical commercial businesses of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, Joaquin also oversees the Operations, Quality, and Compliance functional groups supporting the Pharmaceutical commercial and research and development organizations.
Prior to his current role, Joaquin held the position of Company Group Chairman, The Americas, and led a team responsible for the launches of key pharmaceutical products and for the strong growth of major therapeutic franchises throughout Canada, the U.S. and Latin America. He also held the role of Company Group Chairman, Ortho Clinical Diagnostics, Inc.
Joaquin’s career in the pharmaceutical industry has spanned sales, marketing and general management. He joined Johnson & Johnson in 1989 in Janssen-Cilag Spain and later became Managing Director of Janssen-Cilag Italy. He then led Ortho Biotech Europe before relocating to the United States in 2002 as Vice President for the Ortho Biotech Oncology Franchise. He was named President, Ortho Biotech Products, L.P. in 2005. During his tenure, the company sustained a leadership position in bioscience in difficult market conditions and under significant competitive pressure.
A native of Valencia, Spain, Joaquin holds an undergraduate degree in Economics and two Master’s degrees – one in Business Administration from ESADE Business School in Barcelona; the other in International Management from Thunderbird in Phoenix, Arizona.
Joaquin serves on the Board of Directors of the Pharmaceutical Research & Manufacturers of America (PhRMA), serving as chair of the State Committee and as a member of the Finance and Audit, FDA, Federal, and Communications and Alliance Committees. He also serves as a member of the Board of the European Federation of the Pharmaceutical Industry and Associations (EFPIA), the Board of Trustees of Save the Children and the International Advisory Board of the ESADE Business School.
Joaquin resides in Bridgewater, NJ, with his wife and two children.
Joaquin News & Multimedia
Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, recently spoke about his passion and commitment to diversity and inclusion. Read his remarks in our corporate blog.
For the second consecutive year FORTUNE Magazine ranked Johnson & Johnson and its Janssen Pharmaceutical Companies #1 in the Pharmaceuticals category on its annual World’s Most Admired Companies list. J&J senior leaders Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, and Joaquin Duato, Worldwide Chairman, Janssen Pharmaceutical Companies, co-authored a blog about this honor and our commitment to healthcare innovation.
Joaquin Duato, Worldwide Chairman of our Janssen Pharmaceutical Companies, was asked to participate in the 18th Annual PricewaterhouseCoopers (PwC) LLC Global CEO Survey on behalf of Johnson & Johnson and our senior leadership team. Joaquin shares some of his business perspectives in this interview.
CNBC's Meg Tirrell speaks to Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson about the Company's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
In an interview on Bloomberg TV, Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, discussed our pharmaceutical products launched since 2009, coupled with the new products expected to emerge from our pipeline, are planned to account for nearly half of the total sales in the segment by 2017.
Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson guest authored a blog on Huffington Post’s Global Motherhood blog about his September 2014 trip to Texas to learn about the Save the Children humanitarian work being done to help children.
Johnson & Johnson’s Joaquin Duato and Sarah Colamarino write about the importance of investing in a child’s future from birth through the important developmental years and beyond. Learn how the long-standing partnership between Save the Children and J&J continues to help support children around the globe.